We are looking for young people 2 to 17 years of age to join a Crohn’s disease (CD) trial to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or ulcerative colitis (including associated symptoms such as diarrhea, stomach pain, abdominal pain, chronic fatigue and/or joint pain), consider one of our CD studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.
Your child may be eligible to take part in the CD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
See if your child qualifies.
